论文部分内容阅读
目的:观察稳心颗粒联合倍他乐克治疗急性前壁心梗PCI术后室性早搏的临床疗效。方法:选择50例急性前壁心梗PCI术后室性早搏患者,随机分为治疗组和对照组各25例,对照组给予抗凝、抗血小板、抗动脉硬化、抗缺血、抗重构、抗心衰治疗,包括β受体阻滞剂等规范化治疗,治疗组在上述治疗基础上给予稳心颗粒口服治疗。结果:治疗1个月后两组室早减少情况比较具有显著性差异(P<0.05)。结论:治疗组(稳心颗粒联合倍他乐克组)治疗效果明显好于对照组(倍他乐克组)。
Objective: To observe the clinical effect of Wenxin granule combined with Betaloc in the treatment of ventricular premature beats in patients with acute anterior myocardial infarction. Methods: Fifty patients with premature ventricular premature beats in patients with acute anterior myocardial infarction were randomly divided into treatment group (n = 25) and control group (n = 25). The control group was given anticoagulant, antiplatelet, antiarrhythmic, anti- , Anti-heart failure treatment, including β-blockers and other standardized treatment, the treatment group on the basis of the above treatment given Wenxin particles oral treatment. Results: There was a significant difference between the two groups in the early reduction after 1 month of treatment (P <0.05). Conclusion: The treatment group (Wenshen granules combined with Betaloc group) treatment effect was significantly better than the control group (Betaloc group).